NASDAQ:CDLX Cardlytics (CDLX) Stock Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free CDLX Stock Alerts $11.90 -0.47 (-3.80%) (As of 11:39 AM ET) Add Compare Share Share Today's Range$11.81▼$12.5650-Day Range$6.25▼$20.2552-Week Range$4.94▼$20.52Volume172,385 shsAverage Volume1.53 million shsMarket Capitalization$573.22 millionP/E RatioN/ADividend YieldN/APrice Target$15.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Cardlytics alerts: Email Address Cardlytics MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside25.3% Upside$15.50 Price TargetShort InterestBearish12.35% of Shares Sold ShortDividend StrengthN/ASustainability-0.67Upright™ Environmental ScoreNews Sentiment-0.25Based on 3 Articles This WeekInsider TradingAcquiring Shares$8.96 M Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.44 out of 5 starsBusiness Services Sector125th out of 306 stocksComputer Programming, Data Processing, & Other Computer Related Industry24th out of 60 stocks 3.4 Analyst's Opinion Consensus RatingCardlytics has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageCardlytics has only been the subject of 3 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted12.35% of the outstanding shares of Cardlytics have been sold short.Short Interest Ratio / Days to CoverCardlytics has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cardlytics has recently increased by 32.81%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldCardlytics does not currently pay a dividend.Dividend GrowthCardlytics does not have a long track record of dividend growth. Previous Next 2.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreCardlytics has received a 21.51% net impact score from Upright. Cardlytics seems to create the most significant positive value in categories "Taxes", "Distributing knowledge", and "Jobs". The positive contribution in the "Distributing knowledge" impact category is mostly driven by its "Market intelligence data provision", "Marketing and consumer information services", and "Marketing optimization software" products. See details.Environmental SustainabilityThe Environmental Impact score for Cardlytics is -0.67. Previous Next 1.5 News and Social Media Coverage News SentimentCardlytics has a news sentiment score of -0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cardlytics this week, compared to 2 articles on an average week.Search Interest30 people have searched for CDLX on MarketBeat in the last 30 days. This is an increase of 36% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Cardlytics to their MarketBeat watchlist in the last 30 days. This is a decrease of -62% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cardlytics insiders have bought 1,346.84% more of their company's stock than they have sold. Specifically, they have bought $8,963,613.00 in company stock and sold $619,532.00 in company stock.Percentage Held by InsidersOnly 4.40% of the stock of Cardlytics is held by insiders.Percentage Held by Institutions68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Cardlytics is -3.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cardlytics is -3.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCardlytics has a P/B Ratio of 3.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Cardlytics Stock (NASDAQ:CDLX)Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.Read More CDLX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CDLX Stock News HeadlinesApril 3, 2024 | insidertrades.comCardlytics, Inc. (NASDAQ:CDLX) Insider Nicholas Hollmeyer Lynton Sells 12,460 SharesApril 21, 2024 | americanbankingnews.comNextdoor (NYSE:KIND) versus Cardlytics (NASDAQ:CDLX) Head-To-Head AnalysisApril 24, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.April 19, 2024 | finance.yahoo.comCardlytics, Inc. (CDLX)April 17, 2024 | seekingalpha.comThe Power Of Cardlytics' Data Partnerships Including Bank of AmericaApril 15, 2024 | americanbankingnews.comCardlytics, Inc. (NASDAQ:CDLX) Short Interest Up 32.8% in MarchApril 9, 2024 | globenewswire.comLiane Hornsey Appointed to Cardlytics Board of DirectorsApril 9, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for Cardlytics Amid Growth Prospects and Strategic American Express PartnershipApril 24, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.April 9, 2024 | markets.businessinsider.comThe Analyst Verdict: Cardlytics In The Eyes Of 5 ExpertsApril 8, 2024 | finance.yahoo.comIs There An Opportunity With Cardlytics, Inc.'s (NASDAQ:CDLX) 31% Undervaluation?April 4, 2024 | markets.businessinsider.comCraig-Hallum Reaffirms Their Buy Rating on Cardlytics (CDLX)April 3, 2024 | finance.yahoo.comCardlytics Inc (CDLX) Chief Legal & Privacy Officer Nicholas Lynton Sells 12,460 SharesApril 3, 2024 | finance.yahoo.comCardlytics Inc (CDLX) CEO Karim Temsamani Sells 32,718 SharesApril 2, 2024 | fool.comWhy Cardlytics Stock Skyrocketed 75% Last MonthApril 1, 2024 | msn.comCliff Sosin Portfolio: Inside the Mind of an Investing GeniusMarch 27, 2024 | msn.comWhy Cardlytics (CDLX) Stock Is Down 30%March 27, 2024 | msn.comIs Cardlytics Stock a Buy After Insider's $13.9M Investment?March 26, 2024 | globenewswire.comCardlytics Prices $150.0 Million Convertible Senior Notes OfferingMarch 26, 2024 | fool.comWhy Cardlytics Stock Tanked by 33% TodayMarch 26, 2024 | msn.comCardlytics stock dips on proposed $150M convertible notes offeringMarch 26, 2024 | globenewswire.comCardlytics Announces Proposed Convertible Senior Notes OfferingMarch 24, 2024 | msn.comStellantis, Other Beneficial Owners Love These 7 StocksMarch 21, 2024 | finance.yahoo.comCDLX May 2024 12.500 callMarch 20, 2024 | finance.yahoo.comCDLX Jul 2024 17.500 putMarch 18, 2024 | wsj.comCardlytics Inc.March 16, 2024 | seekingalpha.comCardlytics, Inc. (CDLX) Q4 2023 Earnings Call TranscriptSee More Headlines Receive CDLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2024Today4/24/2024Next Earnings (Estimated)5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Computer programming, data processing, & other computer related Sub-IndustryN/A Current SymbolNASDAQ:CDLX CUSIPN/A CIK1666071 Webwww.cardlytics.com Phone(888) 798-5802FaxN/AEmployees434Year Founded2008Price Target and Rating Average Stock Price Target$15.50 High Stock Price Target$18.00 Low Stock Price Target$9.00 Potential Upside/Downside+25.3%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($3.46) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-134,700,000.00 Net Margins-43.56% Pretax Margin-43.56% Return on Equity-25.38% Return on Assets-8.32% Debt Debt-to-Equity Ratio1.91 Current Ratio1.31 Quick Ratio1.31 Sales & Book Value Annual Sales$309.20 million Price / Sales1.93 Cash Flow$1.23 per share Price / Cash Flow10.02 Book Value$3.43 per share Price / Book3.61Miscellaneous Outstanding Shares48,170,000Free Float46,054,000Market Cap$595.86 million OptionableOptionable Beta1.44 Social Links 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Karim Temsamani (Age 50)CEO & Director Comp: $424.02kMr. Nick LyntonChief Legal & Privacy Officer and SecretaryMs. Alexis DeSienoChief Financial OfficerMr. Amit GuptaCOO & GM of BridgMr. Peter ChanChief Technology OfficerMr. Peter DaviesHead of Sales Strategy & OperationsMs. Carson NappsHead of PeopleMr. Jose SingerChief Product OfficerMs. Evelyne ForesterChief Business OfficerMore ExecutivesKey CompetitorsVimeoNASDAQ:VMEOViant TechnologyNASDAQ:DSPEventbriteNYSE:EBDada NexusNASDAQ:DADATremor InternationalNASDAQ:TRMRView All CompetitorsInsiders & InstitutionsAssenagon Asset Management S.A.Sold 52,380 shares on 4/24/2024Ownership: 0.093%Nicholas Hollmeyer LyntonSold 276 sharesTotal: $3,521.76 ($12.76/share)Shikiar Asset Management Inc.Bought 10,675 shares on 4/22/2024Ownership: 0.083%Check Capital Management Inc. CABought 19,275 shares on 4/19/2024Ownership: 0.088%Los Angeles Capital Management LLCBought 28,370 shares on 4/5/2024Ownership: 0.242%View All Insider TransactionsView All Institutional Transactions CDLX Stock Analysis - Frequently Asked Questions Should I buy or sell Cardlytics stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CDLX shares. View CDLX analyst ratings or view top-rated stocks. What is Cardlytics' stock price target for 2024? 4 brokerages have issued twelve-month target prices for Cardlytics' stock. Their CDLX share price targets range from $9.00 to $18.00. On average, they anticipate the company's stock price to reach $15.50 in the next year. This suggests a possible upside of 25.3% from the stock's current price. View analysts price targets for CDLX or view top-rated stocks among Wall Street analysts. How have CDLX shares performed in 2024? Cardlytics' stock was trading at $9.21 on January 1st, 2024. Since then, CDLX stock has increased by 34.3% and is now trading at $12.37. View the best growth stocks for 2024 here. Are investors shorting Cardlytics? Cardlytics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 5,950,000 shares, an increase of 32.8% from the March 15th total of 4,480,000 shares. Based on an average daily trading volume, of 1,680,000 shares, the days-to-cover ratio is presently 3.5 days. View Cardlytics' Short Interest. When is Cardlytics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our CDLX earnings forecast. How were Cardlytics' earnings last quarter? Cardlytics, Inc. (NASDAQ:CDLX) released its earnings results on Thursday, March, 14th. The company reported ($0.14) EPS for the quarter. The business earned $89.17 million during the quarter. Cardlytics had a negative net margin of 43.56% and a negative trailing twelve-month return on equity of 25.38%. What ETF holds Cardlytics' stock? Invesco Dorsey Wright Technology Momentum ETF holds 380,072 shares of CDLX stock, representing 1.38% of its portfolio. What guidance has Cardlytics issued on next quarter's earnings? Cardlytics issued an update on its first quarter 2024 earnings guidance on Thursday, March, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $70.0 million-$73.0 million, compared to the consensus revenue estimate of $66.5 million. What is Lynne Laube's approval rating as Cardlytics' CEO? 26 employees have rated Cardlytics Chief Executive Officer Lynne Laube on Glassdoor.com. Lynne Laube has an approval rating of 86% among the company's employees. 61.0% of employees surveyed would recommend working at Cardlytics to a friend. What other stocks do shareholders of Cardlytics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include NVIDIA (NVDA), Block (SQ), DocuSign (DOCU), Advanced Micro Devices (AMD), Caterpillar (CAT), Walt Disney (DIS), Alibaba Group (BABA), Trade Desk (TTD), QUALCOMM (QCOM) and Twilio (TWLO). When did Cardlytics IPO? Cardlytics (CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers. Who are Cardlytics' major shareholders? Cardlytics' stock is owned by a number of retail and institutional investors. Top institutional investors include Los Angeles Capital Management LLC (0.24%), Assenagon Asset Management S.A. (0.09%), Check Capital Management Inc. CA (0.09%) and Shikiar Asset Management Inc. (0.08%). Insiders that own company stock include Amit Gupta, Andrew Christiansen, Clifford Sosin, John V Balen, John V Balen, Karim Saad Temsamani, Kirk Somers, Lynne Marie Laube, Nicholas Hollmeyer Lynton, S Aimee Lapic, Scott D Grimes and Scott D Grimes. View institutional ownership trends. How do I buy shares of Cardlytics? Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does Cardlytics have any subsidiaries? The following companies are subsidiares of Cardlytics: Bridg, Cardlytics Services India Private Limited, Cardlytics UK Limited, and DOSH.Read More This page (NASDAQ:CDLX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingPrepare for a recession unlike any otherAmerican Hartford Gold GroupExposed: How Big Banks Plan to Chain Your Wealth with Digital DollarsGoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardlytics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
